Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease-Reference-Cited by-同舟云学术

Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease

Published:2022-12 Issue:2 Volume:58 Page:374-381
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Popler Jonathan¹,Vece Timothy J.²,Liptzin Deborah R.³⁴⁵,Gower William A.²^ORCID

Affiliation:

1. Children's Physician Group—Pulmonology Children's Healthcare of Atlanta Atlanta Georgia USA

2. Division of Pediatric Pulmonology and Program for Rare and Interstitial Lung Disease University of North Carolina School of Medicine Chapel Hill North Carolina USA

3. School of Public and Community Health University of Montana Missoula Montana USA

4. Department of Pediatrics University of Colorado School of Medicine Aurora Colorado USA

5. Department of Pediatrics University of Washington School of Medicine Seattle Washington USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26227

Reference87 articles.

1. An Official American Thoracic Society Clinical Practice Guideline: Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy

2. Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme

3. Diffuse Lung Disease in Young Children

4. Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease

5. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, prevalence, and pattern of medical service utilization of children's rare lung diseases in South Korea;Pediatric Pulmonology;2024-02-19